Results 231 to 240 of about 135,077 (359)

Pharmaceutical and biomedical challenges for crew autonomy in health preservation during future exploration missions. [PDF]

Commun Med (Lond)
Ciofani G, Bandiera T, Corsini A, Crescenzi M, De Vittorio M, Mari S, Martinelli E, Monici M, Piccirillo S, Narici M, Ferranti F.   +10 more
europepmc   +1 more source

Mineralogy and chemistry of San Carlos high-alkali basalts: Analyses of alteration with application for Mars exploration [PDF]

, 2017
Bryné A. Hadnott, B. L. Ehlmann, Bradley L. Jolliff   +2 more
openalex   +1 more source

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebrospinal fluid (CSF) cell‐free mitochondrial DNA (cf‐mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf‐mtDNA levels, body composition, nutritional status, and metabolic biomarkers in PD. Methods CSF cf‐mtDNA levels, defined as the
Yasuaki Mizutani, Tsuyoshi Nakai, Yasuhiro Maeda, Reiko Ohdake, Atsuhiro Higashi, Toshiki Maeda, Ryunosuke Nagao, Sayuri Shima, Kazuya Kawabata, Akihiro Ueda, Mizuki Ito, Hirohisa Watanabe   +11 more
wiley   +1 more source

Developing artificially intelligent agents to support earth independent medical capabilities during human exploration-class space missions. [PDF]

NPJ Microgravity
Buras WR, Hilmers DC.
europepmc   +1 more source

Exploration of Planetary Hyperspectral Images with Unsupervised Spectral Unmixing: A Case Study of Planet Mars [PDF]

, 2018
Jun Liu, Bin Luo, S. Douté, Jocelyn Chanussot   +3 more
openalex   +1 more source

Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MCI) and subjective cognitive decline (SCD).
Giulia Giacomucci, Assunta Ingannato, Chiara Crucitti, Silvia Bagnoli, Elisa Marcantelli, Sonia Padiglioni, Valentina Moschini, Carmen Morinelli, Laura Falsini, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi   +12 more
wiley   +1 more source

Liquid water might not be the only answer: Evaluating pore-filling materials in the Martian crust. [PDF]

Proc Natl Acad Sci U S A
Xiao W, Pan L, Wang Y, Li J.
europepmc   +1 more source

Mars-Relevant Field Experiences in Morocco: The Importance of Spatial Scales and Subsurface Exploration [PDF]

, 2018
Ákos Keresztúri, Zsuzsanna Kapui, G. G. Ori, Kamal Taj-Eddine, Gábor Újvári   +4 more
openalex   +1 more source

Moyamoya Disease and the Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo, Jeong‐Yong Shin, Rugyeom Lee, Jiwon Cheon, Ji Hun Kim, Doeun Kim, Jae‐Kyung Won, In‐Hwan Oh, Yunjong Lee, Tae‐Beom Ahn   +9 more
wiley   +1 more source

Detection of visible-wavelength aurora on Mars. [PDF]

Sci Adv
Knutsen EW, McConnochie TH, Lemmon M, Donaldson C, Francis R, Legett C, Viet SB, Soret L, Toledo D, Apéstigue V, Witasse O, Montmessin F, Jolitz R, Schneider NM, Tamppari L, Cousin A, Wiens RC, Maurice S, Bell JF, Forni O, Lasue J, Pilleri P, Bertrand T, Patel P, Schröder S, Curry S, Lee CO, Rahmati A.   +27 more
europepmc   +1 more source